At the news
? NEUTRALIMPACT 5/10 8-K filed Apr 15, 2026 at 16:08 ET
Wave Life Sciences is redomiciling from Singapore to Delaware, exchanging all Singapore shares for Delaware shares on a one-for-one basis. This move aims to streamline operations and reduce compliance costs while maintaining Nasdaq listing under ticker WVE.
- Wave Life Sciences is changing its corporate domicile from Singapore to Delaware
- All outstanding Singapore shares will be exchanged for Delaware shares on a one-for-one basis
- The redomiciliation requires shareholder and Singapore High Court approval
- The new Delaware entity will trade on Nasdaq under the same WVE ticker
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access